US6962976B2ExpiredUtilityPatentIndex 49
Human TREK2, a stretch- and arachidonic acid-sensitive K+ channel activated by inhalational anesthetics and niluzole
Est. expiryJun 27, 2020(expired)· nominal 20-yr term from priority
C07K 14/705A61P 23/00
49
PatentIndex Score
1
Cited by
10
References
4
Claims
Abstract
This invention relates to a protein including a mammalian K+ channel with two pore domains, designated TREK2, that produces currents whose current-voltage relationship is weakly inward rectifying in high symmetrical K+ conditions. This invention further relates to the isolation and characterization of such protein, as well as a method using TREK2 to identify bioactive compounds having anesthetic properties.
Claims
exact text as granted — not AI-modified1. An isolated and purified protein comprising a mammalian K + channel with two pore domains, wherein said channel produces currents whose current-voltage relationship is weakly inwardly rectifying in high symmetrical K + conditions, and wherein said channel comprises the amino acid sequence of SEQ ID NO: 2.
2. The protein of claim 1 , wherein said channel is a human K + channel.
3. The protein of claim 1 consisting essentially of the amino acid sequence of SEQ ID NO: 2.
4. The mammalian K + channel of claim 1 , wherein said high symmetrical K + conditions is a K + -rich external medium of about 150 mM.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.